CC chemokine receptor 5 polymorphism in Italian patients with giant cell arteritis

REFERENCES

• Gonzalez-Gay MA, Vazquez-Rodriguez TR, Lopez-Diaz MJ, Miranda-Filloy JA, Gonzalez-Juanatey C, Martin J, et al. Epi-demiology of giant cell arteritis and polymialgia rheumatica. Arthritis Rheum. 2009;61:1454–61.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Gay MA, Amoli MM, Garcia-Porrua C, 011ier WR. Genetic markers of disease susceptibility and severity in giant cell arteritis and polymyalgia rheumatica. Semin Arthritis Rheum. 2003;33:38–48.
   Google Scholar
• Weyand CM, Hicok KC, Hunder GG, Goronzy J. The HLA-DRB1 locus as a genetic component in giant cell arteritis. Map-ping of a disease-linked sequence motif to the antigen binding site of the HLA-DR molecule. J Clin Invest. 1992;90:2355–61.
   Google Scholar
• Boiardi L, Casali B, Farnetti E, Pipitone N, Nicoli D, Macchioni P, et al. Interleukin-10 promoter polymorphisms in giant cell arteritis. Arthritis Rheum. 2006;54:4011–7.
   PubMed Web of Science ®Google Scholar
• Salvarani C, Casali B, Nicoli D, Farnetti E, Macchioni P, Catan-oso MG, et al. Endothelial nitric oxide synthase gene polymor-phisms in giant cell arteritis. Arthritis Rheum. 2003;48:3219–23.
   Google Scholar
• Ward SG, Marelli-Berg FM. Mechanisms of chemokine and antigen-dependent T-lymphocyte navigation. Biochem J. 2009; 418:13–27.
   PubMed Web of Science ®Google Scholar
• Charo IF, Ransohoff RM. The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med. 2006;354: 610–21.
   PubMed Web of Science ®Google Scholar
• Mueller A, Strange PG. The chemokine receptor, CCR5. Int J. Biochem Cell Biol. 2004;36:35–8.
   PubMed Web of Science ®Google Scholar
• Briihl H, Vielhauer V, Weiss M, Mack M, Schlöndorff D, Segerer S. Expression of DARC, CXCR3 and CCR5 in giant cell arteritis. Rheumatology. 2005;44: 309–13.
   Google Scholar
• O'Brien SJ, Moore JP. The effect of genetic variation in che-mokines and their receptors on HIV transmission and progression to AIDS. Immunol Rev. 2000;177:99–111.
   PubMed Web of Science ®Google Scholar
• Martens HA, Kallenberg CG, Bijl M. Role of CCR5 delta32 bp deletion in RA and SLE. Autoimmunity. 2009;42: 260–2.
   Google Scholar
• Petrek M, Gibejova A, Drabek J, Mrazek F, Kolek V, Weigl E, et al. CC chemokine receptor 5 (CCR5) mRNA expression in pulmonary sarcoidosis. Immunol Lett. 2002;80(189):93.
   Google Scholar
• Kantor R, Bakhanashvili M, Achiron A. A mutated CCR5 gene may have favorable prognostic implications in MS. Neurology. 2003;61(238):40.
   Google Scholar
• Carmona FD, Rodriguez-Rodriguez L, Castarieda S, Miranda-Filloy JA, Morado IC, Narvdez J, et al. Role of the CCR5/ 432CCR5 polymorphism in biopsy-proven giant cell arteritis. Hum Immunol. 2011;72:458–61.
   PubMedGoogle Scholar
• Gonzalez-Gay MA, Garcia-Porrua C, Llorca J, Gonzalez-Louzao C, Rodriguez-Ledo P. Biopsy-negative giant cell arteritis: clinical spectrum and predictive factors for positive temporal artery biopsy. Semin Arthritis Rheum. 2001;30:249–56.
   PubMed Web of Science ®Google Scholar
• Restuccia G, Cavazza A, Boiardi L, Pipitone N, Macchioni P, Bajocchi G, et al. Small-vessel vasculitis surrounding an unin-flamed temporal artery and isolated vasa vasorum vasculitis of the temporal artery: two subsets of giant cell arteritis. Arthritis Rheum. 2012;64:549–56.
   PubMed Web of Science ®Google Scholar
• Yang B, Houlberg K, Millward A, Demaine A. Polymorphisms of chemokine and chemokine receptors in type 1 diabetes mellitus and its complications. Cytokine. 2004;26:114–21.
   PubMed Web of Science ®Google Scholar
• Odum N, Bregenholt S, Eriksen KW, Skov S, Ryder LP, Bendtzen K, et al. The CC-chemokine receptor 5 (CCR5) is a marker of, but not essential for the development of human Thl cells. Tissue Antigens. 1999;54:572–7.
   PubMed Web of Science ®Google Scholar
• Berce V, Repnik K, Potocnik U. Association of CCR5-delta32 mutation with reduced risk of nonatopic asthma in Slovenian children. J Asthma. 2008;45: 780–4.
   Google Scholar
• Petrek M, Cermáková Z, Hutyrová B, Miceková D, Drábek J, Rovensky J, et al. CC chemokine receptor 5 and interleukin-1 receptor antagonist gene polymorphisms in patients with primary Sjrigren's syndrome. Clin Exp Rheumatol. 2002;20:701–3.
   PubMedGoogle Scholar
• Pokomy V, McQueen F, Yeoman S, Merriman M, Merriman A, Harrison A, et al. Evidence for negative association of the che-mokine receptor CCR5 d32 polymorphism with rheumatoid arthritis. Ann Rheum Dis. 2005;64:487–90.
   PubMedGoogle Scholar
• Zhou Y, Huang D, Farver C, Hoffman GS. Relative importance of CCR5 and antineutrophil cytoplasmic antibodies in patients with Wegener's granulomatosis. J Rheumatol. 2003;30:1541–7.
   PubMedGoogle Scholar
• Petrek M, Drábek J, Kolek V, Zlámal J, Welsh KI, Bunce M, et al. CC chemokine receptor gene polymorphisms in Czech patients with pulmonary sarcoidosis. Am J Respir Crit Care Med. 2000;162:1000–3.
   PubMedGoogle Scholar
• Atzeni F, Boiardi L, Casali B, Fametti E, Sarzi-Puttini PC, Pipitone N et al. CC Chemokine receptor 5 polymorphism in italian patients with Behçet's disease. Rhematology 2012 (in press).
   Google Scholar
• Boiardi L, Vaglio A, Nicoli D, Fametti E, Palmisano A, Pipitone N, et al. CC chemokine receptor 5 polymorphism in chronic periaortitis. Rheumatology. 2011;50:1025–32.
   PubMedGoogle Scholar
• Ghilardi G, Biondi ML, Battaglioli L, Zambon A, Guagnellini E, Scorza R. Genetic risk factor characterizes abdominal aortic aneurysm from arterial occlusive disease in human beings: CCR5 Delta 32 deletion. J Vase Surg. 2004;40:995–1000.
   PubMed Web of Science ®Google Scholar
• Salvarani C, Boiardi L, Timms JM, Silvestri T, Ranzi A, Mac-chioni PL, et al. Absence of the association with CC chemokine receptor 5 polymorphism in polymyalgia rheumatica. Clin Exp Rheumatol. 2000;18: 591–5.
   Google Scholar
• Thou Y, Kurihara T, Ryseck RP, Yang Y, Ryan C, Loy J, et al. Impaired macrophage function and enhanced T cell-dependent immune response in mice lacking CCR5, the mouse homologue of the major HIV-1 coreceptor. J Immunol. 1998;160:4018–25.
   PubMedGoogle Scholar
• Ajuebor MN, Wondimu Z, Hogaboam CM, Le T, Proudfoot AE, Swain MG. CCR5 deficiency drives enhanced natural killer cell trafficking to and activation within the liver in murine T cell-mediated hepatitis. Am J Pathol. 2007;170:1975–88.
   PubMedGoogle Scholar
• Takeuchi A, Usui Y, Takeuchi M, Hattori T, Kezuka T, et al. CCR5-deficient mice develop experimental autoimmune uveo-retinitis in the context of a deviant effector response. Invest Ophthalmol Vis Sci. 2005;46:3753–60.
   PubMed Web of Science ®Google Scholar
• Ramshaw AL, Parums DV. Immunohistochemical characteriza-tion of inflammatory cells associated with advanced atheroscle-rosis. Histopathology. 1990;17:543–52.
   PubMed Web of Science ®Google Scholar
• Ramshaw AL, Roskell DE, Parums DV. Cytokine gene expression in aortic adventitial inflammation associated with advanced ath-erosclerosis (chronic periaortitis). J Clin Pathol. 1994;47:721–7.
   Google Scholar
• Weyand CM, Hicok KC, Hunder GG, Goronzy JJ. Tissue cyto-kine patterns in patients with polymyalgia rheumatica and giant cell arteritis. Ann Intern Med. 1994;121:484–91.
   PubMed Web of Science ®Google Scholar